Tested Applications
| Positive WB detected in | L02 cells, mouse liver tissue, rat brain tissue |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
21503-1-AP targets C19orf44 in WB, IF, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag15960 Product name: Recombinant human C19orf44 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-350 aa of BC027869 Sequence: MASARKASRPMRDVFGDFSDVSLEDSTMEEIRNFQISRNLTKIAPGHSRFLKRNQTLDEKHLLLKENPVLGSGPRLASCRPPTTASRIRANAALMKLAQLETRIMNRKLQRNLSDTESDSMTADAGLPKRADRILSGGALELASQNTDKTSQNQARELPVTENNAQNAKVSRFLKKKQAPVENISPEAPAGKERTLQTPKQKEPARTFDSPDSDEEEMKVLLGSLMDSSREKNTNQGFSSANVSEEEERKLFSVPSQLRAFTVPSVELSSAKPSQTSHLPTSLAADRTLHSTRSRADYPQSHVSSDTASHTPSVSITGAFSNSVSLKMGHVKLVSSPGRSEAETVDEPVS Predict reactive species |
| Full Name | chromosome 19 open reading frame 44 |
| Calculated Molecular Weight | 618 aa, 66 kDa |
| Observed Molecular Weight | 66-71 kDa |
| GenBank Accession Number | BC027869 |
| Gene Symbol | C19orf44 |
| Gene ID (NCBI) | 84167 |
| RRID | AB_2878871 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9H6X5 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for C19orf44 antibody 21503-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The C19orf44 Polyclonal antibody (Cat# 21503-1-AP) has 1 citation to date. It was cited in Genet Med (Impact Factor 6.2) in a 2025 study by Miriam Ehrenberg et al., which investigated biallelic null variants in C19orf44 causing a unique late-onset retinal dystrophy phenotype characterized by patchy perifoveal chorioretinal atrophy. The research field is medical genetics and ophthalmology, specifically retinal degenerative disease. The antibody was used for immunofluorescence (IF) in human samples.
| Species | Application | Title |
|---|---|---|
Genet Med Biallelic null variants in C19orf44 cause a unique late onset retinal dystrophy phenotype characterized by patchy perifoveal chorioretinal atrophy |







